Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
04/2002
04/25/2002US20020049326 Benzosulfones and related compositions and methods
04/25/2002US20020049317 Method for acylating cyclic compounds
04/25/2002US20020049242 Condensed 4,5,6,7-tetrahydrobenzo[C]thiopenes as enhancer for cell differentiation induction factor action
04/25/2002US20020049223 Quinoline and naphthyridine carboxylic acid antibacterials
04/25/2002US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
04/25/2002US20020048779 Method of assaying pyrrole-containing biological compounds
04/24/2002EP0932407A4 Method for treating migraine pain
04/24/2002EP0714299B1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
04/24/2002CN1346358A Thienopyrimidine compounds and salts thereof and process for the preparation of the same
04/24/2002CN1083453C Fused imidazole derivatives as emultidrug resistance modulators
04/23/2002US6376539 Antiischemic agents, central nervous system disorders
04/23/2002US6376521 A3 adenosine receptor antagonists
04/18/2002WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002WO2002030908A1 Inhibitors of protein kinases
04/18/2002WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis
04/18/2002WO2002030860A2 Ketone compounds and compositions for cholesterol management and related uses
04/18/2002WO2001087830A3 Substituted thioacetamides
04/18/2002US20020045640 Anellated dihydropyridines for the treatment of chronic pain
04/18/2002US20020045635 Novel mGluR antagonists and a method for their synthesis
04/18/2002US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/18/2002US20020045194 Proteomic analysis
04/18/2002CA2459746A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002CA2394084A1 Inhibitors of protein kinases
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196199A2 Water soluble multi-biotin-containing compounds
04/17/2002EP1042322B1 Kv2.1 ANTAGONISTS
04/17/2002EP1015434B1 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
04/17/2002EP0807632B1 Pyrroloazepine derivatives
04/17/2002CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
04/17/2002CN1344719A Organic electronic material with thiowhorl structure and its prepn
04/17/2002CN1082963C Isoxazolidine derivatives
04/16/2002US6372750 Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
04/16/2002CA2076948C Isatineoxime derivatives, their preparation and use
04/11/2002WO2002029409A2 Method of assaying pyrrole-containing biological compounds
04/11/2002WO2002028874A2 Tumor proliferation inhibitors
04/11/2002WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
04/11/2002WO2002028837A1 Metabotropic glutamate receptor antagonists
04/11/2002WO2002028830A1 Novel phenylalanine derivatives
04/11/2002US20020042412 Fused azepinone cyclin dependent kinase inhibitors
04/11/2002US20020042411 Condensed thiophene compounds and pharmaceutical use thereof
04/11/2002US20020042409 Thiophene derivatives useful as anticancer agents
04/11/2002CA2425264A1 Tumor proliferation inhibitors
04/11/2002CA2424431A1 Method of assaying pyrrole-containing biological compounds
04/11/2002CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists
04/10/2002EP1194429A1 Potassium channel openers
04/10/2002EP1109802B1 Spirofluorenopyrans
04/10/2002EP0734387B1 Hiv protease inhibitors
04/10/2002CN1344266A Novel compounds
04/09/2002US6369239 Process for the preparation of dialkylthiophenes and alkylenedioxythiophenes
04/09/2002US6369227 Thrombin or factor Xa inhibitors
04/09/2002US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa
04/09/2002US6369222 mGluR antagonists and a method for their synthesis
04/09/2002US6369071 Treatment of angina pectoris
04/09/2002CA2189731C New 1,4-oxazine tetracyclic compounds, process for preparing the same and pharmceutical compositions containing them
04/04/2002WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
04/04/2002WO2001089451A3 Protease inhibitors
04/04/2002US20020040275 Proteomic analysis
04/04/2002US20020040021 Method for treating sexual dysfunction
04/03/2002EP1192465A1 Detection using dendrimers bearing labels and probes
04/03/2002EP1192165A2 Substituted heterocycle fused gamma-carbolines
04/03/2002EP1192164A1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
04/03/2002EP1192163A1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
04/03/2002EP1192129A2 Pharmaceutical compounds
04/02/2002US6365594 As opioid agonists and antagonists and are useful as i.a. analgesics
04/02/2002US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/02/2002US6365586 Compounds, their preparation and use
03/2002
03/28/2002WO2002024703A1 Bicyclic heteroaromatic compounds
03/28/2002WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
03/28/2002WO2002024655A1 Isoquinolinone potassium channel inhibitors
03/28/2002WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
03/28/2002WO2002024230A1 Solid preparations
03/28/2002WO2001095857A3 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates
03/28/2002WO2001064676A3 INHIBITORS OF p38-α KINASE
03/28/2002CA2423329A1 Solid preparations
03/28/2002CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
03/27/2002EP1191020A2 Material for organic electroluminescence device and use thereof
03/27/2002EP1189907A1 Thienopyrimidines as phosphodiesterase inhibitors
03/27/2002EP1189905A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189904A1 Substituted heterocycle fused gamma-carbolines
03/27/2002EP1189890A1 Dihydrobenzodiazepins and their use for treating dyslipidemia
03/27/2002EP0790996B1 Pyridazinoquinoline compounds
03/27/2002CN1342145A Fused-ring compounds and use thereof as drugs
03/27/2002CN1342137A N2 phenylamidine derivatives
03/27/2002CN1342080A Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances
03/27/2002CN1341598A Preparation method of 2-thiophene ethamine
03/27/2002CN1081638C Thienopyrimidines
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362298 High molecular weight; polymerization catalyst
03/26/2002US6362179 Psychological disorders; nervous system disorders
03/26/2002US6362177 Cyclic amine derivatives and their use as drugs
03/21/2002WO2002022611A2 Caspase inhibitors and uses thereof
03/21/2002WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022602A2 Triazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002006361A3 Novel photochromic polymers and methods of synthesizing same